| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding | |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | Entrez:930 MIM:107265 HGNC:HGNC:1633 Ensembl:ENSG00000177455 AllianceGenome:HGNC:1633 | |
| Description | CD19 molecule | |||||
| GTO ID | GTC1914 |
| Trial ID | NCT03574168 |
| Disease | B-Cell Acute Lymphoblastic Leukemia |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | SJCAR19|CD19 CAR-T cells |
| Generation | 2nd |
| Phase | Phase1 |
| Recruitment status | Unknown |
| Title | CD19-CAR-T Cells in Patients With R/R B-ALL |
| Year | 2018 |
| Country | China |
| Company sponsor | Bioceltech Therapeutics, Ltd. |
| Other ID(s) | BT-ALL-001-v2|ChiCTR1800016541 |
| Vector information | |||||
|
|||||
| Cohort 1 | |||||||||
|
|||||||||